Vivimed Labs may touch Rs 600, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities.
Bandyopadhyay told CNBC-Awaaz, "One can invest in Vivimed Labs with a long term view. The stock is getting on low valuation; we can see level of Rs 600 in stock in next 1 year time."
The company touched its 52-week high Rs 444.00 and 52-week low Rs 212.50 on 18 Apr, 2012 and 18 Nov, 2011, respectively. Currently, it is trading -8.32% below its 52-week high and 91.55% above its 52-week low.
--Warm Regards,Uttam